PNC Financial Services Group
AQST icon

PNC Financial Services Group’s Aquestive Therapeutics AQST Stock Holding History

PNC Financial Services Group’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$522K Buy
125,537
+125,527
+1,255,270% +$528K ﹤0.01% 1758
2026
Q1 		$42 Sell
10
-163
-94% -$662 ﹤0.01% 5134
2025
Q4 		$1.12K Sell
173
-50
-22% -$312 ﹤0.01% 4668
2025
Q3 		$1.25K Buy
+223
New +$964 ﹤0.01% 4630

Other funds holding AQST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
EAM
Everstar Asset Management Mooresville, North Carolina $207M AUM 18.14% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PNC Financial Services Group's AQST Position: Q2 2026 in Review

PNC Financial Services Group increased its Aquestive Therapeutics (AQST) stake by 1,255,270% in Q2 2026, buying an estimated $528K and bringing the position to 125,537 shares worth $522K. The position accounts for ﹤0.01% of the portfolio, ranked #1758.

PNC Financial Services Group first reported a position in AQST in Q3 2025 and has held it in 4 quarters since. 76 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • PNC Financial Services Group held 125,537 shares of Aquestive Therapeutics worth $522K as of Q2 2026.
  • PNC Financial Services Group bought 125,527 Aquestive Therapeutics shares in Q2 2026, an estimated $528K.
  • Aquestive Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1758 holding.
  • PNC Financial Services Group first reported a position in Aquestive Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 76 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.